U.S. Life Sciences Stock News

Allegion plc recently reported its second-quarter 2026 results, with sales rising to US$1,151.5 million and net income reaching US$184.6 million, while also lifting its full-year revenue and earnings guidance on the back of strong organic growth and margin expansion in the Americas. A key takeaway is Allegion’s continued focus on capital deployment, completing a US$1.18 billion share repurchase program that retired more than one-tenth of its shares since 2020. We’ll now examine how...

In the second quarter of 2026, Preferred Bank reported net interest income of US$69.99 million and net income of US$33.54 million, with both basic and diluted earnings per share from continuing operations increasing compared with a year earlier. Alongside this earnings growth, the bank materially improved its credit profile by cutting non-performing loans by US$70 million and criticized loans by US$90 million, while signaling some pressure ahead on net interest margins. Next, we’ll examine...

Matador Resources stock has delivered a 77.7% gain over the past five years, yet the latest valuation checks still point to shares screening as cheap rather than fully priced in. Over five years, a 77.7% return suggests Matador Resources has already rewarded patient shareholders while still leaving room to question whether the current price fully reflects its fundamentals. The planned US$1.275b acquisition of Paloma Permian may support future production and cash flow, while the recent...

United Bankshares (UBSI) opened Q2 2026 with revenue of US$318.9 million and basic EPS of US$0.95. Trailing 12 month figures show revenue of about US$1.3 billion and basic EPS of US$3.72, setting a clear earnings benchmark for investors watching this season. Over the last few quarters, the company has seen revenue move from US$300.1 million in Q2 2025 to US$311.6 million in Q4 2025 and US$308.8 million in Q1 2026, alongside EPS ranging between US$0.85 and US$0.92 before landing at US$0.95...

AppFolio (APPF) has just posted Q2 2026 results with revenue of US$281.1 million and basic EPS of US$1.17, set against a trailing twelve month picture that shows revenue of about US$1.0 billion and EPS of US$4.41. The company has seen quarterly revenue move from US$235.6 million in Q2 2025 to US$281.1 million in Q2 2026, while basic EPS over the same quarters went from US$1.00 to US$1.17. This leaves investors to weigh those headline gains against a period of compressed margins and what that...

New tariffs of 10% to 12.5% on imports tied to forced labor allegations are reshaping the cost equation for U.S. businesses, and small caps that manufacture close to home could see their relative position change. With importers facing higher input costs and ongoing debate about how tariffs flow through to household budgets, investors are looking again at companies that lean on domestic supply. This article explains how the latest trade policy shift might affect U.S. small caps and highlights...

Stubbornly high grocery bills, rising interest in store brands and price rollbacks at big retailers are reshaping where consumer dollars go and which companies keep more of each sale. For investors, this mix of pressure on traditional brands and opportunity for lower cost alternatives can make private label and store brand producers worth a closer look, whether you prefer stability, growth potential or resilience when budgets tighten. This article breaks down how the latest trends could...

Equinix stock has delivered a 45.8% total return over the past five years, yet the valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to roughly 30.4% undervaluation while earnings based multiples lean the other way. Over five years, Equinix has returned 45.8%. This puts the recent share price performance firmly in focus when judging whether the current level still makes sense. Growing demand for data center capacity in markets such as Switzerland...

Talos Energy stock has delivered a strong 69.9% return over the past year, and a key consideration for investors now is how that rally lines up with valuation checks that still suggest the shares screen as cheap on several measures. The 69.9% one-year gain highlights how quickly sentiment has shifted in favor of Talos Energy, putting more pressure on the current valuation to be supported by fundamentals from here. Recent gains linked to US-Iran tensions and higher perceived oil supply risk...

Tariffs have moved from political headline to portfolio issue, with new US import duties of 10% to 12.5% affecting nearly all goods from about 60 trading partners and drawing immediate legal and international pushback. For US domestic manufacturing stocks, this mix of higher import costs, possible retaliation, and supply chain strain can create both fresh openings and new risks. This article looks at how that backdrop connects to companies in the US Domestic Manufacturing Stocks screener and...

Dover (DOV) has just posted Q2 2026 results with revenue of US$2.2b and basic EPS of US$2.32, set against trailing 12 month revenue of US$8.4b and EPS of US$8.32, where earnings over the past year grew 5.5%. Over recent quarters the company has seen revenue move from US$2.0b in Q2 2025 to US$2.1b in Q4 2025 and US$2.2b in Q2 2026. Quarterly basic EPS shifted from US$2.04 to US$2.02 and then US$2.32, setting up a picture of steady top line with earnings that investors can weigh against a...

CRISPR Therapeutics (NasdaqGM:CRSP) has moved its allogeneic CAR T candidate CTX112 into Phase 1 clinical trials. The program targets lymphoma and certain autoimmune diseases with an off the shelf cell therapy approach. The company is positioning CTX112 within the broader CAR T market, which currently relies heavily on individualized patient specific treatments. For investors following CRISPR Therapeutics, CTX112 marks a meaningful extension of the company’s focus beyond its earlier gene...

Global Partners stock has delivered a 168.2% return over the past 5 years, and with the shares recently closing at US$48.38, the key question is whether the current valuation still points to a bargain or if much of that upside is already reflected in the price. Over the last 5 years, Global Partners has returned 168.2%. This puts the focus firmly on whether the current price still offers an appealing entry point after such a strong run. Future earnings and cash flow expectations can support...

We wouldn't blame CrowdStrike Holdings, Inc. ( NASDAQ:CRWD ) shareholders if they were a little worried about the fact...

Enova International (ENVA) has just posted Q2 2026 results with revenue of US$470.2 million and basic EPS of US$4.22, set against trailing 12 month revenue of about US$1.7 billion and EPS of US$14.30 that reflect a 38.7% earnings increase over the past year. Over the last six reported quarters, revenue has moved from US$345.6 million in Q1 2025 to US$470.2 million in Q2 2026, while quarterly basic EPS has shifted from US$2.84 to US$4.22. This gives investors a clearer view of how top line and...

Mobileye Global (MBLY) has reported Q2 2026 revenue of US$508 million with a basic EPS loss of US$0.03 and net income loss of US$21 million, putting fresh numbers in front of a market already focused on the company’s path to profitability. Over recent quarters the company has seen revenue move between US$438 million and US$558 million, while basic EPS has ranged from a small loss of US$0.03 to a much larger quarterly loss of US$4.67, highlighting how volatile reported earnings have been...

Nordic American Tankers reported that the tanker market remains exceptionally strong, while three vessels previously trapped in the Arabian Gulf since February 28, 2026 have been released and returned to global trading, and a separate Black Sea attack caused only minor damage with the crew unharmed. This combination of a very strong operating backdrop and the restoration of previously disrupted capacity materially improves the company’s near‑term operational flexibility and earnings...

Paychex stock has retreated over the past year, yet the current US$113.55 share price sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while traditional earnings multiples look roughly in line with the market. That split leaves investors weighing a seemingly attractive DCF signal against a more neutral read from broader valuation checks. Over the last 12 months, Paychex has delivered a decline of 20.7%, which puts recent returns at...

Rising tensions in the Red Sea have put critical shipping lanes and energy infrastructure in the spotlight, and that is feeding directly into how investors think about large infrastructure and engineering stocks. When oil routes and key facilities face higher security risks, the companies that build, maintain or secure essential assets can see sentiment shift quickly, for better or worse. This article looks at three stocks from our Global Infrastructure & Engineering Companies screener that...

Investors in CSX Corporation ( NASDAQ:CSX ) had a good week, as its shares rose 4.9% to close at US$53.23 following the...

Kinder Morgan, Inc. ( NYSE:KMI ) just released its quarterly report and things are looking bullish. The company beat...

SS&C Technologies Holdings (SSNC) has reported a clean set of Q2 2026 numbers, with revenue of US$1.7 billion and basic EPS of US$0.99, alongside trailing 12 month EPS of US$3.58. Over the past few quarters the company has seen revenue move from US$1.54 billion in Q2 2025 to US$1.70 billion in Q2 2026, while basic EPS has risen from US$0.74 to US$0.99. This puts the focus on how a 13.2% trailing net margin shapes the quality of these results for investors. See our full analysis for SS&C...

Alignment Healthcare stock has delivered a very strong 237.9% return over the past three years, yet its valuation checks still suggest the shares screen as cheap rather than stretched. That contrast is now running head on into fresh legal and regulatory questions that could affect how investors think about the quality and sustainability of the company’s earnings. A 237.9% three year gain positions Alignment Healthcare as a major winner over that period, so any hint that its growth story is...

Tenet Healthcare (THC) has reported another strong quarter, with Q2 2026 revenue of US$6.1 billion, basic EPS of US$9.89 and net income excluding extraordinary items of US$826 million setting the tone. The company’s quarterly revenue increased from US$5.3 billion in Q2 2025 to US$6.1 billion in Q2 2026, while basic EPS rose from US$3.16 to US$9.89 over the same period. Trailing 12 month earnings growth of 51% has coincided with a net profit margin that improved to 9.9% from 7.2% a year...